doi: 10.1080/19390211.2021.1874587 55
BPC-157 (body protection compound), is an endogenous, stable pentadecapeptide 15 amino acids first derived from gastric juices
They are the most frequently reported adverse events across every clinical trial conducted to date
Dietary Modifications Since the liver is already working overtime to process TMA, reducing other dietary sources of TMA can help lighten the load [6]
Its ~5day halflife allows convenient onceweekly subcutaneous dosing [1]
For each included study, data was extracted on study design, baseline population characteristics, intervention details (type and dose of GLP-1 receptor agonists), comparator, mean follow-up duration and reported cardiovascular outcomes